The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...
FDA sought policy recommendations on mental health medical devices, including AI-enabled. After I reviewed submissions, one ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...
The agency’s sweeping rollout and staff challenge underscore rising momentum behind agentic AI: advanced, multiagent systems ...
5don MSN
US FDA approves first AI tool for liver disease trials: How AIM-NASH transforms biopsy reading
NASH, has received FDA approval to revolutionize liver disease drug trials. This innovative technology assists pathologi ...
PathAI, a global leader in AI-powered pathology, today announced that the U.S. Food and Drug Administration (FDA) has ...
Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...
The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...
Had DOGE embraced an AI-first strategy, the United States might today be leading the world in digital governance, offering ...
Deputy Secretary of the Department of Health and Human Services Jim O’Neill is bringing a Silicon Valley attitude to AI use and regulation at the agency. | At an event hosted on Wednesday, O'Neill ...
MedPage Today on MSNOpinion
AI Isn't the Solution for Every Problem
Instead of hunting for problems for AI to solve and implementing systems often backed with limited to no evidence or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback